23/09/2024
As part of his colorectal cancer treatment, Chad Smith decided to participate in a phase 2 clinical trial evaluating the intravenous injection of a dye during his surgery.
“As a surgeon, I think you always have to look for ways to innovate, to make surgery less invasive and to help people recover faster. This study will help determine whether injecting a dye can improve visualization of the ureter during surgery, potentially making the operation safer and also reducing the risk of complications," says Laila Rashidi, MD, FACS, FASCRS, a board-certified colorectal surgeon at MultiCare and principal investigator on the trial.
MultiCare Tacoma General Hospital is one of only three sites in the country, and worldwide, conducting this study for colorectal surgery. The MultiCare Institute for Research & Innovation partners with MultiCare facilities, like Tacoma General, as well as community medical practices, to elevate patient care through research.
A colorectal cancer survivor sees a clinical trial as an opportunity to benefit “the greater good” while potentially improving his surgical outcome.